Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Melanoma 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Automobiles 3fludarabine 2Sirolimus 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Cyclophosphamide 2trametinib 1sonidegib 1ripretinib 1ribociclib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1keyhole-limpet hemocyanin 1interferon gamma-1b 1guadecitabine 1fludarabine phosphate 1Vorinostat 1Topotecan 1Tetrahydrouridine 1Tetanus Toxoid 1Stem Cell Transplantation 1Simvastatin 1Photochemotherapy 1Oncolytic Virotherapy 1Mesna 1Melphalan 1Interferon-gamma 1Immunotherapy 1Filgrastim 1Dihematoporphyrin Ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms, Germ Cell and Embryonal × Tetrahydrouridine × Clear all
NCT02839694 2018-07-05

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡